Abstract
1. Arnason BGW. Acute inflammatory demyelinating polyradiculoneuropathies. In: Dyck P J, Thomas PK, Lambert EH, Bunge R, eds. Peripheral neuropathy. 2nd ed. Philadelphia: WB Saunders, 1984:2050-100. 2. Weinberg GA, Granoff DM. Polysaccharide-protein conjugate vaccines for the prevention of Hemophilus influenzae type b disease. J PEDIATR 1988;113:621-31. 3. Appelbaum E, Greenberg M, Nelson J. Neurological complications following antirabies vaccination. JAMA 1953; 151:18891. 4. Keenlyside RA, Schonberger LB, Bregman D J, Sullivan Bolyai JZ. Fatal Guillain-Barr6 syndrome after the national influenza immunization program. Neurology 1980;30:929-33. 5. Hurwitz ES, Holman RC, Nelson DB, Schonberger LB. National surveillance for Guillain-Barr6 syndrome: January 1978March 1979. Neurology 1983;33:150-7. 6. Miller HG, Stanton JB. Neurological sequelae of prophylactic innoculation. Q J Med 1954;23:1-27. 7. Pollard JD, Selby G. Relapsing neuropathy due to tetanus toxoid: report of a case. J Neurol Sci 1978;37:113-25. 8. Samantray SK, Johnson SC, Mathai KV, Pulimood BM. Landry-Guillain-Barr6-Strohl syndrome: a study of 302 cases. Med J Aust 1977;2:84-91. 9. Leneman F. The Guillain-Barr6 syndrome: definition, etiology and review of 1,100 cases. Arch Intern Med 1966;118:139-44. 10. Grose C, Spigland I. Guillain-Barr6 syndrome following administration of live measles vaccine. Am J Med 1976;60: 441-3. 11. Gunderman JR. Guillain-Barr6 syndrome: occurence following combined mumps-rubella vaccine. Am J Dis Child 1973; 125:834-5. 12. Friedland ML, Wittels EG. An unusual neurologic reaction following polyvalent pneumococcal vaccine in a patient with hairy cell leukemia. Am J Hematol 1983;14:189-91. 13. Kurland LT, Wiederbolt WC, Kirkpatrick JW, Potter HG, Armstrong P. Swine influenza vaccine and Guillain-Barr6 syndrome: epidemic or artifact? Arch Neurol 1985;42:108990. 14, Poser CM. Swine influenza vaccination: truth and consequences. Arch Neurol 1985;42:1090-2. 15. Kinnunen E, Fg.rkkil~i M, Hovi T, Juntunen J, Weckstr6m P. Incidence of Guillain-Barr6 syndrome during a nationwide oral poliovirus vaccine campaign. Neurology 1989;39:1034-6.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
